NZ239909A - Anti hiv agents containing glycoprotein cd-4 and dextrin sulphate - Google Patents
Anti hiv agents containing glycoprotein cd-4 and dextrin sulphateInfo
- Publication number
- NZ239909A NZ239909A NZ239909A NZ23990991A NZ239909A NZ 239909 A NZ239909 A NZ 239909A NZ 239909 A NZ239909 A NZ 239909A NZ 23990991 A NZ23990991 A NZ 23990991A NZ 239909 A NZ239909 A NZ 239909A
- Authority
- NZ
- New Zealand
- Prior art keywords
- agent
- agents containing
- hiv agents
- anti hiv
- containing glycoprotein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
The invention provides an agent against HIV and related viruses, in dosage unit form, comprising CD4 or a CD4-like material and a polyanionic anti-HIV agent, the content of CD4 or CD4-like material in the agent being less than the anti-virally effective dose of the CD4 or CD4-like material alone. It has been found that when the CD4 or CD4-like material is used together with a polyanionic anti-HIV agent, the combination is more effective against HIV infection than would be the case if the anti-viral effect was simply additive.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909020872A GB9020872D0 (en) | 1990-09-25 | 1990-09-25 | Pharmaceutical compositions and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ239909A true NZ239909A (en) | 1993-02-25 |
Family
ID=10682731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ239909A NZ239909A (en) | 1990-09-25 | 1991-09-23 | Anti hiv agents containing glycoprotein cd-4 and dextrin sulphate |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0550529A1 (en) |
JP (1) | JPH06502846A (en) |
AU (1) | AU653962B2 (en) |
CA (1) | CA2092093A1 (en) |
GB (1) | GB9020872D0 (en) |
IE (1) | IE913341A1 (en) |
NZ (1) | NZ239909A (en) |
PT (1) | PT99058B (en) |
WO (1) | WO1992004909A1 (en) |
ZA (1) | ZA917596B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5272261A (en) * | 1989-01-11 | 1993-12-21 | Merrell Dow Pharmaceuticals Inc. | Preparation of sulfated polysaccharide fractions |
GB9209874D0 (en) * | 1992-05-07 | 1992-06-24 | Ml Lab Plc | Pharmaceutical compositions |
FR2838649B1 (en) * | 2002-04-19 | 2006-01-13 | Commissariat Energie Atomique | ANTI-HIV COMPOSITION, METHOD OF MANUFACTURE AND MEDICINAL PRODUCT |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0293826A3 (en) * | 1987-06-02 | 1989-05-10 | Stichting REGA V.Z.W. | Therapeutic and prophylactic application of sulfated polysaccharides against aids |
DE3808353A1 (en) * | 1988-03-12 | 1989-09-21 | Basf Ag | COMBINATIONS OF POLYSULFATED HEPARINES IN THE FIGHT AGAINST RETROVIRUS INFECTIONS |
WO1989011860A1 (en) * | 1988-06-10 | 1989-12-14 | Biogen, Inc. | Combinations of soluble t4 proteins and anti-retroviral agents and methods for treating or preventing aids, arc and hiv infection |
WO1990000596A1 (en) * | 1988-07-07 | 1990-01-25 | The Trustees Of The University Of Pennsylvania | Method of modulating virus-host cell interactions using carbohydrates and carbohydrate derivatives |
-
1990
- 1990-09-25 GB GB909020872A patent/GB9020872D0/en active Pending
-
1991
- 1991-09-23 NZ NZ239909A patent/NZ239909A/en unknown
- 1991-09-23 CA CA002092093A patent/CA2092093A1/en not_active Abandoned
- 1991-09-23 JP JP3515281A patent/JPH06502846A/en active Pending
- 1991-09-23 AU AU86127/91A patent/AU653962B2/en not_active Ceased
- 1991-09-23 EP EP91916829A patent/EP0550529A1/en not_active Withdrawn
- 1991-09-23 WO PCT/GB1991/001627 patent/WO1992004909A1/en not_active Application Discontinuation
- 1991-09-24 IE IE334191A patent/IE913341A1/en not_active Application Discontinuation
- 1991-09-24 ZA ZA917596A patent/ZA917596B/en unknown
- 1991-09-25 PT PT99058A patent/PT99058B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT99058B (en) | 1999-02-26 |
EP0550529A1 (en) | 1993-07-14 |
JPH06502846A (en) | 1994-03-31 |
PT99058A (en) | 1992-08-31 |
IE913341A1 (en) | 1992-02-25 |
CA2092093A1 (en) | 1992-03-26 |
WO1992004909A1 (en) | 1992-04-02 |
ZA917596B (en) | 1992-05-27 |
AU653962B2 (en) | 1994-10-20 |
AU8612791A (en) | 1992-04-15 |
GB9020872D0 (en) | 1990-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20022752B (en) | Valaciclovir Tablets Containing Colloidal Silicon Dioxide | |
USD347299S (en) | Valve cover | |
MX170010B (en) | IMPROVEMENTS RELATED TO SMOKING ITEMS | |
KR830008774A (en) | Cutting insert | |
GR3000707T3 (en) | Synergistic association of amantadine and selegiline | |
GT199800126A (en) | COMBINATION THERAPY. | |
TR200003635T2 (en) | The use of Peg-IFN-ALFA and ribavirin in chronic hepatitis C treatment. | |
NZ225775A (en) | Prophylactic sheath: microcapsules between elastomeric layers | |
NZ324603A (en) | Treatment of the CNS effects of HIV with VX-478, alone or in combination with AZT or 3TC | |
ES8601698A1 (en) | Pharmaceutical compositions based on heparin and surfactants having an effect on the mucous membranes of the mouth, the nose and/or the throat. | |
ZA906187B (en) | Pharmaceutical compositions | |
DE69613058D1 (en) | Prevention and treatment of topical viral infections with perfluoropolyethers or their compositions | |
DK486189D0 (en) | PSYLLIUM FRESH CALLS AND AGENTS COMPREHENSIVE TOGETHER | |
USD262095S (en) | Packaging container for needles or the like | |
NZ239909A (en) | Anti hiv agents containing glycoprotein cd-4 and dextrin sulphate | |
MY106371A (en) | Oral pharmaceutical compositions in unit dosage form | |
ATE130516T1 (en) | ANTI-HIV REMEDIES. | |
ZA903334B (en) | Cleansing composition | |
AU2880595A (en) | Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses | |
FR2522968B1 (en) | CYTOTOXIC DRUG FORM OF THE ASSOCIATION OF AT LEAST ONE IMMUNOTOXIN AND CHLOROQUIN | |
CO4870753A1 (en) | ABSORBENT STRUCTURE WITH IMPROVED ABSORPTION PROPERTIES | |
ATE122206T1 (en) | REDUCTION AND INHIBITION OF THE CONTENT OF ETHYLENETHIOUREA IN ALKYLENE BISDITHIOCARBAMATES. | |
CA2082270A1 (en) | Anti-viral therapy | |
ES8700940A1 (en) | Improvements relating to the treatment control and prevention of rhinovirus infections. | |
DE69103458D1 (en) | Reduction and prevention of the ETU content in alkylene bisdithiocarbamates. |